Open AccessSafety and efficacy of an Anti-CD20 Monoclonal antibody (RedituxTM) In Indian patients with seropositive rheumatoid arthritis
Author(s) -
Arun Hegde,
Vivek Vasdev,
Krishnan Shanmuganandan,
Kavita Singh,
Sivasami Kartik,
Abhishek Kumar
Publication year - 2018
Publication title -
indian journal of rheumatology/indian journal of rheumatology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.155
H-Index - 11
eISSN - 0973-3701
pISSN - 0973-3698
DOI - 10.4103/injr.injr_98_17
Subject(s) - medicine , rheumatoid arthritis , rituximab , erythrocyte sedimentation rate , clinical endpoint , rheumatism , adverse effect , gastroenterology , clinical trial , lymphoma